Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has reached agreement with the majority shareholders of Sias to acquire Sias AG, a leading OEM supplier of a wide range of modular and complete laboratory automation solutions. Sias will become a part of Tecan’s Partnering Business, leveraging Tecan’s global sales […]
Cambridge, UK : Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, today announced it has entered into a new agreement with Swift Biosciences (Swift). Swift will be incorporating Horizon’s human genomic reference standards into its […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology Company, announced today it has signed an agreement with UC San Francisco’s (UCSF) Catalyst Program to support its research efforts. Under the agreement, a Sigma-Aldrich representative will participate in reviewing and consulting for projects in the Catalyst Awards program, which funds UCSF […]
SANTA CLARA, Calif. & HALIFAX, Nova Scotia — Affymetrix Inc. (NASDAQ: AFFX) and Athletigen Technologies Inc., a direct-to-consumer sports genetics company, today announced a global partnership agreement. Under the agreement, Athletigen will use Affymetrix Axiom® genotyping platform for its sports-related DNA analysis service. DNA from a saliva sample will be genotyped using Athletigen’s DNA microarray […]
SAN DIEGO, Calif. — Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY® Dx PLUS assays for gene-specific mutation testing to aid in the selection of targeted therapy regimens. Agena Bioscience will introduce the first diagnostic kits in partnership with Diatech Pharmacogenetics. The MassARRAY Dx PLUS assays improve upon existing methods […]
HILLSBORO, Ore. — FEI Company (NASDAQ:FEIC) and DCG Systems, Inc. today announced a definitive agreement under which FEI would acquire DCG for $160 million in an all cash transaction. DCG is a leading supplier of electrical fault characterization, localization and editing equipment, serving process development, yield ramp and failure analysis applications for a wide range […]
MILFORD, Mass. — Waters Corporation (NYSE: WAT) today welcomed the Shanghai Institute of Materia Medica’s (SIMM) Research Center for Modernization of Traditional Chinese Medicineunder the direction of Dr. De-an Guo into the Waters Centers of Innovation (COI) Program. The Research Center plays a leading role in the effort to develop standardized methods for analyzing the […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that it agreed to sell its Sigma-Aldrich-branded solvents and inorganics business in the EEA to Honeywell. The sale will also include global rights to the Company’s Fluka® brand. This sale is intended to fulfill the commitments the Company made to the European Union in order to […]
Darmstadt, Germany – Merck today announced that SigmaAldrich, the U.S. life science company it plans to acquire, agreed to sell parts of its solvents and inorganics business in Europe to Honeywell in fulfilment of commitments made to the European Union in order to win antitrust approval for its $17 billion acquisition of Sigma-Aldrich. Merck has […]
MORRIS PLAINS, N.J. — Honeywell (NYSE: HON) today announced that it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro. The acquired Sigma-Aldrich business develops and manufactures high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
